Roche To Teach Bangladesh’s Beximco To Make Invirase AIDS Drug (Bangladesh)
This article was originally published in PharmAsia News
Executive Summary
Roche Holding says it plans to teach Bangladesh's Beximco Pharmaceuticals how to make one of its AIDS drugs to help stem the spread of HIV. The company plans to send teams to Beximco and to three companies in Africa to work at the local facilities and help them produce Invirase (saquinavir mesylate). Roche has agreements with nine companies in developing countries already and is considering applications from 26 others. (Click here for more